APA (7th ed.) Citation

K, U., A, H., C, P., C, H., TE, B., F, H., . . . Y, C. (2026). Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance. Drug metabolism and pharmacokinetics, 66, 101512. https://doi.org/10.1016/j.dmpk.2025.101512

Chicago Style (17th ed.) Citation

K, Umehara, et al. "Future Directions in Drug-drug Interaction Evaluations: Industry Perspective on the ICH M12 Guidance." Drug Metabolism and Pharmacokinetics 66 (2026): 101512. https://doi.org/10.1016/j.dmpk.2025.101512.

MLA (9th ed.) Citation

K, Umehara, et al. "Future Directions in Drug-drug Interaction Evaluations: Industry Perspective on the ICH M12 Guidance." Drug Metabolism and Pharmacokinetics, vol. 66, 2026, p. 101512, https://doi.org/10.1016/j.dmpk.2025.101512.